Evaluation of the Frequency and Severity of Sleep Abnormalities in Patients With Parkinson's Disease

Clinical trial NCT04387812 · UNKNOWN

Trial details

NCT number: NCT04387812
Sponsor: Tel-Aviv Sourasky Medical Center
Status: UNKNOWN
Phase: Not Applicable
Study type: INTERVENTIONAL

Parkinson Disease GBA Gene Mutation Leucine-rich Repeat Kinase 2 (LRRK2) Gene Mutation

Start date: 2020-06-01
Primary completion: 2023-12-31
Enrollment: 240

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.